{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:17:34Z","timestamp":1775020654163,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Pharmacists oversee parenteral drug preparation and administration in hospitals, clinics, infusion centers, and home infusion settings. Infusion-related phlebitis (IRP), the most common complication of intravenous infusion therapy, significantly impacts therapeutic outcomes, patient satisfaction, cost of care, and provider workload. Here we review the major etiologies of IRP and describe potential pharmacological and nonpharmacological interventions for preventing and managing the condition as well as for improving vascular access health in multiple-drug administration settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Many parenterally administered drugs cause phlebitis due to mechanical, chemical, or infectious etiologies. Pharmacists can recommend nonpharmacological strategies to mitigate phlebitis, including \u00adjudicious device selection and placement; adjustment of the drug concentration, flow rate, or formulation; infusion site rotation; and use of inline filters to minimize contaminant particulates. Pharmacological treatments for phlebitis include topical, local, and systemic anti-inflammatory and analgesic agents that can reduce symptom severity and prevent further treatment complications or delays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Pharmacists can contribute a unique perspective to interprofessional teams tasked with making policy and formulary decisions that minimize the negative impacts of IRP on drug delivery and patient outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxad090","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T23:09:41Z","timestamp":1683155381000},"page":"974-983","source":"Crossref","is-referenced-by-count":5,"title":["The pharmacist\u2019s role in reducing infusion-related phlebitis"],"prefix":"10.1093","volume":"80","author":[{"given":"Jessica L","family":"Johnson","sequence":"first","affiliation":[{"name":"William Carey University School of Pharmacy , Biloxi, MS , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory","family":"Norton","sequence":"additional","affiliation":[{"name":"William Carey University School of Pharmacy , Biloxi, MS , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Fryfogle","sequence":"additional","affiliation":[{"name":"William Carey University School of Pharmacy , Biloxi, MS , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy K","family":"Fincher","sequence":"additional","affiliation":[{"name":"William Carey University School of Pharmacy , Biloxi, MS , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A","family":"Burmeister","sequence":"additional","affiliation":[{"name":"William Carey University School of Pharmacy , Biloxi, MS , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"issue":"1-2","key":"2023072218484920900_CIT0001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.hjdsi.2016.04.004","article-title":"Home infusion: safe, clinically effective, patient preferred, and cost saving","volume":"5","author":"Polinski","year":"2017","journal-title":"Healthcare"},{"key":"2023072218484920900_CIT0002","first-page":"20","article-title":"A multi-center study of home infusion services in rural areas. Infusion J","author":"Ward","year":"2022"},{"issue":"1","key":"2023072218484920900_CIT0003","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.2146\/ajhp150201","article-title":"Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy program","volume":"73","author":"Chung","year":"2016","journal-title":"Am J Health-Syst Pharm"},{"issue":"6","key":"2023072218484920900_CIT0004","first-page":"CD009162","article-title":"Aloe vera for prevention and treatment of infusion phlebitis","volume":"2014","author":"Zheng","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2023072218484920900_CIT0005","first-page":"31","article-title":"Reaching one peripheral intravenous catheter (PIVC) per patient visit with lean multimodal strategy: the PIV5Rights Bundle. J Assoc Vasc Access","author":"Steere","year":"2019"},{"key":"2023072218484920900_CIT0006","first-page":"1","article-title":"Supplement to \u201cInfusion nursing standards of practice\u201d","volume":"34","author":"Infusion Nurses Society","year":"2011","journal-title":"J Infusion Nurs"},{"issue":"21","key":"2023072218484920900_CIT0007","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.12968\/bjon.1998.7.21.5551","article-title":"I.V.-related phlebitis, complications and length of hospital stay: 1","volume":"7","author":"Campbell","year":"1998","journal-title":"Br J Nurs"},{"issue":"10","key":"2023072218484920900_CIT0008","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(07)70235-9","article-title":"Intravascular catheter-related infections: advances in diagnosis, prevention, and management","volume":"7","author":"Raad","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"2023072218484920900_CIT0009","first-page":"84","article-title":"Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infusion Nurs","author":"Dychter","year":"2012"},{"issue":"2","key":"2023072218484920900_CIT0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/jac\/dkh056","article-title":"Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis","volume":"53","author":"Lanbeck","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2023072218484920900_CIT0011","first-page":"74","article-title":"Pharmacological interventions to treat phlebitis: systematic review. J Infusion Nurs","author":"dos Reis","year":"2009"},{"key":"2023072218484920900_CIT0012","first-page":"230","article-title":"Short peripheral intravenous catheters and infections. J Infusion Nurs","author":"Hadaway","year":"2012"},{"issue":"2","key":"2023072218484920900_CIT0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1757177415624752","article-title":"Development of the UK Vessel Health and Preservation (VHP) framework: a multi-organisational collaborative","volume":"17","author":"Hallam","year":"2016","journal-title":"J Infect Prev"},{"key":"2023072218484920900_CIT0014","first-page":"338","article-title":"Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. J Infusion Nurs","author":"Gallant","year":"2006"},{"issue":"3","key":"2023072218484920900_CIT0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/jcm9030701","article-title":"The development and testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for patients receiving anthracycline chemotherapy for breast cancer","volume":"9","author":"Harris","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"2023072218484920900_CIT0016","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1590\/0104-1169.0192.2603","article-title":"Risk factor for phlebitis: a questionnaire study of nurses\u2019 perception","volume":"23","author":"Milutinovi\u0107","year":"2015","journal-title":"Rev Lat Am Enfermagem"},{"issue":"3","key":"2023072218484920900_CIT0017","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1129729819877323","article-title":"The incidence and risk of infusion phlebitis with peripheral intravenous catheters: a meta-analysis","volume":"21","author":"Lv","year":"2020","journal-title":"J Vasc Access"},{"issue":"5","key":"2023072218484920900_CIT0018","first-page":"247","article-title":"Infusion phlebitis in post-operative patients: when and why","volume":"29","author":"Monreal","year":"1999","journal-title":"Haemostasis"},{"issue":"4","key":"2023072218484920900_CIT0019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.amjmed.2019.08.054","article-title":"Peripheral vein thrombophlebitis in the upper extremity: a systematic review of a frequent and important problem","volume":"133","author":"Heng","year":"2020","journal-title":"Am J Med"},{"issue":"14","key":"2023072218484920900_CIT0020","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.12968\/bjon.2011.20.Sup7.S16","article-title":"Incidence and predisposing factors of phlebitis in a surgery department","volume":"20","author":"do Rego Furtado","year":"2011","journal-title":"Br J Nurs"},{"issue":"7","key":"2023072218484920900_CIT0021","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/00365540110080908","article-title":"Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study","volume":"34","author":"Lanbeck","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"2023072218484920900_CIT0022","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1745-7599.2008.00305.x","article-title":"Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study","volume":"20","author":"Uslusoy","year":"2008","journal-title":"J Am Acad Nurse Pract"},{"issue":"1","key":"2023072218484920900_CIT0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40560-020-00518-4","article-title":"Occurrence and incidence rate of peripheral intravascular catheter-related phlebitis and complications in critically ill patients: a prospective cohort study (AMOR-VENUS study)","volume":"9","author":"Yasuda","year":"2021","journal-title":"J Intensive Care"},{"issue":"11","key":"2023072218484920900_CIT0024","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/jan.12403","article-title":"Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi-centre prospective study","volume":"70","author":"Cicolini","year":"2014","journal-title":"J Adv Nurs"},{"issue":"1","key":"2023072218484920900_CIT0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jvn.2016.11.001","article-title":"Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: a randomized clinical trial","volume":"35","author":"Ayat-Isfahani","year":"2017","journal-title":"J Vasc Nurs"},{"key":"2023072218484920900_CIT0026","first-page":"e2746","article-title":"Incidence of phlebitis associated with the use of peripheral IV catheter and following catheter removal","volume":"24","author":"de Souza Urbanetto","year":"2016","journal-title":"Rev Lat Am Enfermagem"},{"issue":"2","key":"2023072218484920900_CIT0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1129729821989165","article-title":"WoCoVA consensus on the clinical use of in-line filtration during intravenous infusions: current evidence and recommendations for future research","volume":"23","author":"Van Boxtel","year":"2022","journal-title":"J Vasc Access"},{"issue":"6","key":"2023072218484920900_CIT0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jclinane.2007.02.011","article-title":"Esmolol pretreatment reduces the frequency and severity of pain on injection of rocuronium","volume":"19","author":"Yavascaoglu","year":"2007","journal-title":"J Clin Anesth"},{"issue":"9","key":"2023072218484920900_CIT0029","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2023072218484920900_CIT0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/js980051i","article-title":"Formulation-related problems associated with intravenous drug delivery","volume":"87","author":"Yalkowsky","year":"1998","journal-title":"J Pharm Sci"},{"issue":"3","key":"2023072218484920900_CIT0031","first-page":"216","article-title":"A review of pH and osmolarity","volume":"6","author":"Stranz","year":"2002","journal-title":"Int J Pharm Compd"},{"issue":"6","key":"2023072218484920900_CIT0032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0899-9007(98)00037-9","article-title":"Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells","volume":"14","author":"Kuwahara","year":"1998","journal-title":"Nutrition"},{"issue":"4","key":"2023072218484920900_CIT0033","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jps.2600840427","article-title":"Effect of pH on injection phlebitis","volume":"84","author":"Simamora","year":"1995","journal-title":"J Pharm Sci"},{"issue":"1","key":"2023072218484920900_CIT0034","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.xphs.2017.10.030","article-title":"Overcoming the challenges of low drug solubility in the intravenous formulation of solithromycin","volume":"107","author":"Evans","year":"2018","journal-title":"J Pharm Sci"},{"key":"2023072218484920900_CIT0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2017.05.008","article-title":"Novel strategies for the formulation and processing of poorly water-soluble drugs","volume":"126","author":"G\u00f6ke","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"2023072218484920900_CIT0036","first-page":"3689","article-title":"Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study","volume":"7","author":"Song","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"1-2","key":"2023072218484920900_CIT0037","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2004.07.019","article-title":"The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs","volume":"284","author":"Kipp","year":"2004","journal-title":"Int J Pharm"},{"issue":"1","key":"2023072218484920900_CIT0038","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4037\/ccn2019381","article-title":"Phlebitis in intravenous amiodarone administration: incidence and contributing factors","volume":"39","author":"Oragano","year":"2019","journal-title":"Crit Care Nurse"},{"issue":"2","key":"2023072218484920900_CIT0039","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/AAC.03694-14","article-title":"Influence of vancomycin infusion methods on endothelial cell toxicity","volume":"59","author":"Drouet","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2023072218484920900_CIT0040"},{"issue":"5","key":"2023072218484920900_CIT0041","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00520-011-1166-0","article-title":"Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin","volume":"20","author":"Nagata","year":"2012","journal-title":"Support Care Cancer"},{"issue":"1","key":"2023072218484920900_CIT0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2023072218484920900_CIT0043","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2044.1998.00405.x","article-title":"Pain on injection of propofol","volume":"53","author":"Tan","year":"1998","journal-title":"Anaesthesia"},{"key":"2023072218484920900_CIT0044","doi-asserted-by":"crossref","first-page":"d1110","DOI":"10.1136\/bmj.d1110","article-title":"Prevention of pain on injection of propofol: systematic review and meta-analysis","volume":"342","author":"Jalota","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"2023072218484920900_CIT0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0259-1162.84180","article-title":"Preclusion of pain on injection with propofol: evaluating the effects of lignocaine or fentanyl pretreatment","volume":"5","author":"Pal","year":"2011","journal-title":"Anesth Essays Res"},{"key":"2023072218484920900_CIT0046","first-page":"70","article-title":"Adding lidocaine to IV potassium infusions can cause safety problems. P&T","author":"Grissinger","year":"2008"},{"issue":"3","key":"2023072218484920900_CIT0047","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0261-5614(96)80037-9","article-title":"Experimental infusion phlebitis: importance of titratable acidity on phlebitic potential of infusion solution","volume":"15","author":"Kuwahara","year":"1996","journal-title":"Clin Nutr"},{"issue":"2","key":"2023072218484920900_CIT0048","first-page":"143","article-title":"Increase in venous complications associated with etomidate use during a propofol shortage: an example of clinically important adverse effects related to drug substitution","volume":"11","author":"Kosarek","year":"2011","journal-title":"Ochsner J"},{"key":"2023072218484920900_CIT0049"},{"key":"2023072218484920900_CIT0050"},{"issue":"5","key":"2023072218484920900_CIT0051","doi-asserted-by":"crossref","first-page":"e13114","DOI":"10.1111\/ecc.13114","article-title":"Epirubicin chemotherapy in women with breast cancer: alternating arms for intravenous administration to reduce chemical phlebitis","volume":"28","author":"Roberts","year":"2019","journal-title":"Eur J Cancer Care"},{"issue":"7","key":"2023072218484920900_CIT0052","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00520-011-1244-3","article-title":"Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention","volume":"20","author":"Yamada","year":"2012","journal-title":"Support Care Cancer"},{"issue":"2","key":"2023072218484920900_CIT0053","first-page":"e58793","article-title":"Incidence of phlebitis and post-infusion phlebitis in hospitalised adults","volume":"38","author":"de Souza Urbanetto","year":"2017","journal-title":"Rev Gaucha Enferm"},{"issue":"4","key":"2023072218484920900_CIT0054","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7150\/ijms.5.218","article-title":"Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits","volume":"5","author":"Kohno","year":"2008","journal-title":"Int J Med Sci"},{"issue":"5","key":"2023072218484920900_CIT0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00540-017-2386-3","article-title":"Preventive effect of a vapocoolant spray on propofol-induced pain: a prospective, double-blind, randomized study","volume":"31","author":"Moon","year":"2017","journal-title":"J Anesth"},{"issue":"6","key":"2023072218484920900_CIT0056","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4097\/kjae.2015.68.6.556","article-title":"Effects of a fentanyl-propofol mixture on propofol injection pain: a randomized clinical trial","volume":"68","author":"Kizilcik","year":"2015","journal-title":"Korean J Anesthesiol"},{"issue":"3","key":"2023072218484920900_CIT0057","first-page":"53","article-title":"Comparison and evaluation of propofol injection pain with two different doses of fentanyl in fentanyl-propofol mixture","volume":"7","author":"Hashim","year":"2017","journal-title":"Int J Med Pharm Sci."},{"issue":"10","key":"2023072218484920900_CIT0058","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s42399-020-00456-0","article-title":"A modern approach to the Bier block technique","volume":"2","author":"Yari","year":"2020","journal-title":"SN Compr Clin Med"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxad090\/50482450\/zxad090.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/80\/15\/974\/50931128\/zxad090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/80\/15\/974\/50931128\/zxad090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T18:49:24Z","timestamp":1690051764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/80\/15\/974\/7151092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":58,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,5,3]]},"published-print":{"date-parts":[[2023,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxad090","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,1]]},"published":{"date-parts":[[2023,5,3]]}}}